Join us for a high-impact Venture Investor & Partnering (VIP) Forum with Daiichi Sankyo, a global pharmaceutical leader with roots in Japan and operations spanning more than 30 countries. With over 120 years of scientific expertise, Daiichi Sankyo combines a rich legacy of innovation with a robust pipeline of promising new medicines. The company is committed to improving patient outcomes through both innovative and generic medicines, as well as cutting-edge approaches to drug discovery and delivery. This mission is powered by the knowledge, dedication, and creativity of its 19,000+ employees worldwide.
The Daiichi Sankyo VIP Forum is a unique two-part event designed for Washington state life science companies and researchers to learn, connect, and explore opportunities for collaboration. Participants will gain insight into Daiichi Sankyo’s areas of focus, investment approach, and partnering priorities, while engaging directly with a global industry leader.
Sept 22 – Educational Program & Networking
All companies and researchers are invited to join this first session, which features a concise, high-impact program followed by a networking reception with refreshments. Participants will have the chance to hear directly from Daiichi Sankyo, ask questions, and meet peers in the local life sciences community.
Agenda:
- 3:45 PM – Registration & Doors Open
- 4:00 PM – Welcome & Introduction
- 4:10 PM – Daiichi Sankyo Presentation
- 4:45 PM – Q&A
- 5:30 PM – Networking
Sept 23 – Curated One-on-One Meetings
The second day offers an exclusive opportunity for selected researchers and founders whose work aligns with Daiichi Sankyo’s strategic goals to participate in individualized meetings with the company. Applications for these curated meetings will open in July and notifications will be sent by August 1. Space is limited, and some companies may be waitlisted.
This VIP Forum is your gateway to building relationships with one of the world’s leading pharmaceutical innovators. Don’t miss this chance to learn, connect, and position your organization for future collaboration with Daiichi Sankyo.
